BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22186784)

  • 61. The Myb-p300 Interaction Is a Novel Molecular Pharmacologic Target.
    Liu X; Gold KA; Dmitrovsky E
    Mol Cancer Ther; 2015 Jun; 14(6):1273-5. PubMed ID: 25995438
    [No Abstract]   [Full Text] [Related]  

  • 62. MYB deficiency leads to myeloid neoplasia too.
    Gonda TJ
    Blood; 2023 Apr; 141(15):1786-1787. PubMed ID: 37052943
    [No Abstract]   [Full Text] [Related]  

  • 63. Unraveling the Role of Epithelial-Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review.
    Hoch CC; Stögbauer F; Wollenberg B
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma.
    Xu LH; Zhao F; Yang WW; Chen CW; Du ZH; Fu M; Ge XY; Li SL
    Int J Oncol; 2019 May; 54(5):1579-1590. PubMed ID: 30896785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.
    Davis NM; Sokolosky M; Stadelman K; Abrams SL; Libra M; Candido S; Nicoletti F; Polesel J; Maestro R; D'Assoro A; Drobot L; Rakus D; Gizak A; Laidler P; Dulińska-Litewka J; Basecke J; Mijatovic S; Maksimovic-Ivanic D; Montalto G; Cervello M; Fitzgerald TL; Demidenko Z; Martelli AM; Cocco L; Steelman LS; McCubrey JA
    Oncotarget; 2014 Jul; 5(13):4603-50. PubMed ID: 25051360
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.
    Pieraccioli M; Imbastari F; Antonov A; Melino G; Raschellà G
    Cell Cycle; 2013 Jul; 12(14):2309-20. PubMed ID: 24067373
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.
    Hugo HJ; Saunders C; Ramsay RG; Thompson EW
    J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):109-19. PubMed ID: 26193871
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Progress of research on Proto-oncogene c-myc, c-myb in platelet diseases].
    Zhang Y; Chen R; Zhao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):274-8. PubMed ID: 21362267
    [TBL] [Abstract][Full Text] [Related]  

  • 70. c-MYB and TGFβ: EMT's dynamic duo in breast cancer.
    Sala A
    Cell Cycle; 2012 Jan; 11(1):17. PubMed ID: 22186784
    [No Abstract]   [Full Text] [Related]  

  • 71. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
    Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
    Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myb: getting involved in EMT.
    Ramsay R
    Cell Cycle; 2012 Feb; 11(3):433-4. PubMed ID: 22293402
    [No Abstract]   [Full Text] [Related]  

  • 73. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
    Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A supervised network analysis on gene expression profiles of breast tumors predicts a 41-gene prognostic signature of the transcription factor MYB across molecular subtypes.
    Liu LY; Chang LY; Kuo WH; Hwa HL; Chang KJ; Hsieh FJ
    Comput Math Methods Med; 2014; 2014():813067. PubMed ID: 24639887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.